Apr 18 |
PureTech Health: Notice of Results
|
Apr 16 |
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
|
Apr 11 |
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
|
Apr 9 |
PureTech launches Seaport, hoping to create Karuna 2.0
|
Apr 9 |
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
|
Apr 2 |
PureTech Health (PRTC) is on the Move, Here's Why the Trend Could be Sustainable
|
Mar 23 |
PureTech Health: Repeat What Works
|
Mar 19 |
PureTech announces $100M capital return through tender offer
|
Mar 19 |
PureTech Proposes $100 Million Capital Return
|
Mar 18 |
Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion
|